Literature DB >> 32611766

The transcription factors aryl hydrocarbon receptor and MYC cooperate in the regulation of cellular metabolism.

M Carmen Lafita-Navarro1, Lizbeth Perez-Castro1, Lauren G Zacharias2, Spencer Barnes3, Ralph J DeBerardinis2,4, Maralice Conacci-Sorrell5,6,7.   

Abstract

The transcription factor AHR (aryl hydrocarbon receptor) drives the expression of genes involved in detoxification pathways in cells exposed to pollutants and other small molecules. Moreover, AHR supports transcriptional programs that promote ribosome biogenesis and protein synthesis in cells stimulated to proliferate by the oncoprotein MYC. Thus, AHR is necessary for the proliferation of MYC-overexpressing cells. To define metabolic pathways in which AHR cooperates with MYC in supporting cell growth, here we used LC-MS-based metabolomics to examine the metabolome of MYC-expressing cells upon AHR knockdown. We found that AHR knockdown reduced lactate, S-lactoylglutathione, N-acetyl-l-alanine, 2-hydroxyglutarate, and UMP levels. Using our previously obtained RNA sequencing data, we found that AHR mediates the expression of the UMP-generating enzymes dihydroorotate dehydrogenase (quinone) (DHODH) and uridine monophosphate synthetase (UMPS), as well as lactate dehydrogenase A (LDHA), establishing a mechanism by which AHR regulates lactate and UMP production in MYC-overexpressing cells. AHR knockdown in glioblastoma cells also reduced the expression of LDHA (and lactate), DHODH, and UMPS but did not affect UMP levels, likely because of compensatory mechanisms in these cells. Our results indicate that AHR contributes to the regulation of metabolic pathways necessary for the proliferation of transformed cells.
© 2020 Lafita-Navarro et al.

Entities:  

Keywords:  MYC (c-Myc); aryl hydrocarbon receptor (AHR); cancer; gene regulation; glioblastoma; glycolysis; metabolism; metabolomics; oncogene; pyrimidine

Year:  2020        PMID: 32611766      PMCID: PMC7458811          DOI: 10.1074/jbc.AC120.014189

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.

Authors:  David R Wise; Ralph J DeBerardinis; Anthony Mancuso; Nabil Sayed; Xiao-Yong Zhang; Harla K Pfeiffer; Ilana Nissim; Evgueni Daikhin; Marc Yudkoff; Steven B McMahon; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

2.  L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer.

Authors:  Eun-Hee Shim; Carolina B Livi; Dinesh Rakheja; Jubilee Tan; Daniel Benson; Vishwas Parekh; Eun-Young Kho; Arindam P Ghosh; Richard Kirkman; Sadanan Velu; Shilpa Dutta; Balachandra Chenna; Shane L Rea; Robert J Mishur; Qiuhua Li; Teresa L Johnson-Pais; Lining Guo; Sejong Bae; Shi Wei; Karen Block; Sunil Sudarshan
Journal:  Cancer Discov       Date:  2014-09-02       Impact factor: 39.397

3.  MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion.

Authors:  Milind D Chalishazar; Sarah J Wait; Fang Huang; Abbie S Ireland; Anandaroop Mukhopadhyay; Younjee Lee; Sophia S Schuman; Matthew R Guthrie; Kristofer C Berrett; Jeffery M Vahrenkamp; Zeping Hu; Marek Kudla; Katarzyna Modzelewska; Guoying Wang; Nicholas T Ingolia; Jason Gertz; David H Lum; Sabina C Cosulich; John S Bomalaski; Ralph J DeBerardinis; Trudy G Oliver
Journal:  Clin Cancer Res       Date:  2019-06-04       Impact factor: 12.531

4.  The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.

Authors:  M Carmen Lafita-Navarro; Judit Liaño-Pons; Andrea Quintanilla; Ignacio Varela; Rosa Blanco; Fabiana Ourique; Gabriel Bretones; Julia Aresti; Ester Molina; Patrick Carroll; Peter Hurlin; Octavio A Romero; Montse Sanchez-Céspedes; Robert N Eisenman; M Dolores Delgado; Javier León
Journal:  J Biol Chem       Date:  2020-01-09       Impact factor: 5.157

5.  c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism.

Authors:  S R Eberhardy; P J Farnham
Journal:  J Biol Chem       Date:  2001-10-22       Impact factor: 5.157

Review 6.  Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals.

Authors:  Michael S Denison; Scott R Nagy
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

7.  A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria.

Authors:  Rim Rzem; Maria Veiga-da-Cunha; Gaëtane Noël; Sophie Goffette; Marie-Cécile Nassogne; Brahim Tabarki; Christina Schöller; Thorsten Marquardt; Miikka Vikkula; Emile Van Schaftingen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-17       Impact factor: 11.205

Review 8.  Metabolic reprogramming and cancer progression.

Authors:  Brandon Faubert; Ashley Solmonson; Ralph J DeBerardinis
Journal:  Science       Date:  2020-04-10       Impact factor: 47.728

Review 9.  Regulation of mammalian nucleotide metabolism and biosynthesis.

Authors:  Andrew N Lane; Teresa W-M Fan
Journal:  Nucleic Acids Res       Date:  2015-01-27       Impact factor: 16.971

10.  MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer.

Authors:  Niranjan Venkateswaran; M Carmen Lafita-Navarro; Yi-Heng Hao; Jessica A Kilgore; Lizbeth Perez-Castro; Jonathan Braverman; Nofit Borenstein-Auerbach; Min Kim; Nicholas P Lesner; Prashant Mishra; Thomas Brabletz; Jerry W Shay; Ralph J DeBerardinis; Noelle S Williams; Omer H Yilmaz; Maralice Conacci-Sorrell
Journal:  Genes Dev       Date:  2019-08-15       Impact factor: 11.361

View more
  5 in total

1.  Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling.

Authors:  Manon Watzky; Solène Huard; Ludmila Juricek; Julien Dairou; Caroline Chauvet; Xavier Coumoul; Anne Letessier; Benoit Miotto
Journal:  Nucleic Acids Res       Date:  2022-06-10       Impact factor: 19.160

Review 2.  Regulation of Nucleolar Activity by MYC.

Authors:  Isabella N Brown; M Carmen Lafita-Navarro; Maralice Conacci-Sorrell
Journal:  Cells       Date:  2022-02-07       Impact factor: 7.666

3.  Blockade of PGK1 and ALDOA enhances bilirubin control of Th17 cells in Crohn's disease.

Authors:  Marta Vuerich; Na Wang; Jonathon J Graham; Li Gao; Wei Zhang; Ahmadreza Kalbasi; Lina Zhang; Eva Csizmadia; Jason Hristopoulos; Yun Ma; Efi Kokkotou; Adam S Cheifetz; Simon C Robson; Maria Serena Longhi
Journal:  Commun Biol       Date:  2022-09-21

4.  Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells.

Authors:  Martina Karasová; Jiřina Procházková; Zuzana Tylichová; Radek Fedr; Miroslav Ciganek; Miroslav Machala; Zdeněk Dvořák; Barbora Vyhlídalová; Iveta Zůvalová; Jiří Ehrmann; Jan Bouchal; Zdeněk Andrysík; Jan Vondráček
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

5.  Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.

Authors:  M Carmen Lafita-Navarro; Niranjan Venkateswaran; Jessica A Kilgore; Suman Kanji; Jungsoo Han; Spencer Barnes; Noelle S Williams; Michael Buszczak; Sandeep Burma; Maralice Conacci-Sorrell
Journal:  PLoS Genet       Date:  2020-11-17       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.